Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVATIVE: Cyclosporine A in Vernal Keratoconjunctivitis
NCT00328653Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Start
- May 2006
- Primary completion
- Feb 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in Vernal Keratoconjunctivitis (VKC), sponsored by Santen Pharmaceutical. Started May 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT00328653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328653.